London Stock Exchange · Healthcare
Invest in Beximco Pharmaceuticals stock from India
Indian and foreign residents can buy Beximco Pharmaceuticals (BXP) shares directly through Paasa.
By Paasa · Updated
Beximco Pharmaceuticals at a glance
- Price
- £0.51-£0.03 (5.82%)
- Market cap
- £228.99M
- Day range
- £0.51 – £0.54
- P/E
- 4.37
- Dividend yield
- 4.52%
- Volume
- 19.86K
- 1 month
- -6.67%
- 6 months
- +20.78%
- YTD
- +20.78%
- 1 year
- +12.81%
- 5 years
- -46.25%
Beximco Pharmaceuticals statements, FY2020–FY2024
| Fiscal year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | BDT 49.1B | BDT 44.4B | BDT 39.3B | BDT 34.7B | BDT 29.5B |
| Gross profit | BDT 22.3B | BDT 19.6B | BDT 17.1B | BDT 15.8B | BDT 13.9B |
| Operating income | BDT 9.8B | BDT 8.7B | BDT 7.2B | BDT 6.9B | BDT 6.7B |
| Net income | BDT 6.9B | BDT 5.8B | BDT 4.6B | BDT 5.1B | BDT 5.1B |
| Earnings per share | BDT 15.56 | BDT 13.07 | BDT 10.34 | BDT 11.48 | BDT 11.49 |
| EBITDA | BDT 12.0B | BDT 10.6B | BDT 9.4B | BDT 8.2B | BDT 7.4B |
| Total assets | BDT 73.2B | BDT 69.3B | BDT 69.2B | BDT 66.1B | BDT 52.2B |
| Total debt | BDT 5.0B | BDT 6.0B | BDT 10.6B | BDT 12.4B | BDT 7.6B |
| Cash and short-term investments | BDT 2.6B | BDT 1.1B | BDT 1.3B | BDT 1.3B | BDT 675.5M |
| Shareholders' equity | BDT 53.1B | BDT 47.9B | BDT 43.7B | BDT 40.6B | BDT 37.0B |
| Operating cash flow | BDT 7.2B | BDT 8.4B | BDT 6.1B | BDT 5.2B | BDT 6.0B |
| Free cash flow | BDT 4.2B | BDT 6.1B | BDT 3.4B | BDT 2.6B | BDT 3.5B |
| Capital expenditure | −BDT 3.0B | −BDT 2.2B | −BDT 2.7B | −BDT 2.9B | −BDT 2.6B |
Fiscal years as reported, the latest ending 30 Jun 2025. Figures in BDT; a dash means the provider reported nothing for that line.
Peer comparison
| Company | Ticker | Price | Market cap |
|---|---|---|---|
| Optima Health | OPT.L | £2.44 | £264.87M |
| Animalcare | ANCR.L | £3.35 | £231.30M |
| Tristel | TSTL.L | £4.10 | £196.79M |
| Diaceutics | DXRX.L | £1.92 | £162.07M |
| EKF Diagnostics | EKF.L | £0.25 | £105.86M |
| Bioventix | BVXP.L | £17.00 | £88.82M |
| Venture Life | VLG.L | £0.66 | £79.20M |
| Faron Pharmaceuticals Oy | FARN.L | £0.38 | £74.43M |
Peers as grouped by the data provider. This is not an investment recommendation.
How to invest in Beximco Pharmaceuticals from India
Step 1
Open your Paasa account
KYC takes a few minutes: PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Step 2
Add funds from your Indian bank account
Remit up to $250,000 a year under the RBI's Liberalised Remittance Scheme. Your bank converts the rupees to US dollars at its rate on the day you remit, and Interactive Brokers converts the dollars to GBP when you buy.
Step 3
Search BXP and buy
Find Beximco Pharmaceuticals by name or by its ticker, BXP, and place your order.
Why invest in Beximco Pharmaceuticals from India
What Beximco Pharmaceuticals does
Established in 1976 and headquartered in Dhaka, Bangladesh, Beximco Pharmaceuticals Limited is a prominent company engaged in the production and distribution of generic pharmaceutical formulations and active pharmaceutical ingredients (APIs). The firm’s extensive product line addresses a wide range of therapeutic areas, including treatments for allergic disorders, pain and fever, various infections (antibacterial and antiviral), cardiovascular conditions, central nervous system ailments, respiratory illnesses, endocrine disorders, diabetes, gastrointestinal problems, hormonal therapies, onc… Beximco Pharmaceuticals operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector.
Paasa handles the paperwork
Investing abroad brings paperwork with it: remittance filings, capital gains reporting, foreign asset disclosure. Paasa prepares all of it for you. Your India-ready tax reports arrive at year end, ready to file.
Frequently asked questions
Can I buy Beximco Pharmaceuticals stock from India?
Yes. Indian residents and NRIs can buy Beximco Pharmaceuticals (BXP) shares directly through Paasa. Beximco Pharmaceuticals is listed on the London Stock Exchange, in the Drug Manufacturers - Specialty & Generic industry. Your money leaves India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name at Interactive Brokers.
How are Beximco Pharmaceuticals dividends taxed for Indian investors?
Beximco Pharmaceuticals trades on the London Stock Exchange but is domiciled in Bangladesh, so any withholding on its dividends follows that country's rules rather than those of the UK. Dividends are taxed at your slab rate in India. Paasa's dividend report shows the gross amount and any tax withheld for each payment.
What tax do I pay in India when I sell Beximco Pharmaceuticals shares?
Non-residents are exempt from UK capital gains tax on the disposal of listed shares. In India, gains on shares held for more than 24 months are long-term and taxed at 12.5%, and gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. Both are worked out in rupees at the GBP/INR rate on the day you bought and the day you sold, so the currency move is part of the gain. Paasa's capital-gains statement gives you the figures for your return.
Is there stamp duty when I buy Beximco Pharmaceuticals shares?
The UK charges 0.5% Stamp Duty Reserve Tax when buying direct company shares electronically on the LSE; ETFs and UCITS funds do not attract it.